Results of experimental studies on cancer dissemination, as well as ce
rtain clinical observations, strongly suggest a relation between infla
mmation and tumor spread. Surgical trauma and postoperative septic com
plications can result in severe inflammation and in consequence worsen
ing prognosis after curative surgery for colorectal cancer. Clinical s
igns of inflammation, such as fever, elevated leucocytosis and/or C-re
active protein seem to be of poor prognostic significance, heralding r
ecurrence of cancer. If so, it could be hypothesized that non-steroida
l anti-inflammatory drugs may play a beneficial role in reduction of c
ancer relapses. To evaluate the above hypothesis, non-steroidal anti-i
nflammatory drugs are suggested as an adjuvant postoperative treatment
in a clinical trial on humans.